199 related articles for article (PubMed ID: 21499309)
1. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.
Lind GE; Raiborg C; Danielsen SA; Rognum TO; Thiis-Evensen E; Hoff G; Nesbakken A; Stenmark H; Lothe RA
Oncogene; 2011 Sep; 30(37):3967-78. PubMed ID: 21499309
[TBL] [Abstract][Full Text] [Related]
2. Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer.
Zhang H; Song YC; Dang CX
Int J Med Sci; 2013; 10(3):230-4. PubMed ID: 23372428
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.
Bethge N; Lothe RA; Honne H; Andresen K; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
Epigenetics; 2014 Mar; 9(3):428-36. PubMed ID: 24362313
[TBL] [Abstract][Full Text] [Related]
4. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
[TBL] [Abstract][Full Text] [Related]
5. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
[TBL] [Abstract][Full Text] [Related]
6. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
[TBL] [Abstract][Full Text] [Related]
7. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
8. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
[TBL] [Abstract][Full Text] [Related]
9. Spastic Paraplegia 20 and Serine/Threonine Protein Kinase 31 Expression for the Detection of Colorectal Cancer.
Hassan NA; Idriss NK; Gaber N; Ibrahim A; Tawfeek MA; Mossad E; Mosa AA; Ahmed EH; Sayed SA; Ahmed HA; Mohamed AAM
Cell Physiol Biochem; 2022 Apr; 56(2):138-149. PubMed ID: 35389570
[TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of SRY-Box 21 (
Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
[TBL] [Abstract][Full Text] [Related]
11. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
15. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
18. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.
Mayor R; Casadomé L; Azuara D; Moreno V; Clark SJ; Capellà G; Peinado MA
Br J Cancer; 2009 May; 100(10):1534-9. PubMed ID: 19384295
[TBL] [Abstract][Full Text] [Related]
19. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
20. Methylation Heterogeneity and Gene Expression of SPG20 in Solid Tumors.
Cusenza VY; Braglia L; Frazzi R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
